Bogdan Mitran

uppsala university

H指数:28

被引数:1,640

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biodistribution and radiation dosimetry of the PDGFRβ targeting PET tracer [68Ga]Ga-ATH001

PDGFRβ靶向PET示踪剂[68Ga]Ga-ATH001的生物分布与辐射剂量学研究

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2026-09-080

OAAI

[⁶⁸Ga]Ga-NOTA-ATH001 positron emission tomography as a general tool for non-invasive detection of platelet derived growth factor receptor beta in mesenchymal cells

[<sup>68</sup>Ga]Ga-NOTA-ATH001正电子发射断层扫描作为一种非侵入性检测间充质细胞中血小板源性生长因子受体β的工具

Nuclear Medicine and Biology

IF3

2026-05-280

OAAI

Increased affinity by dimerization of radiolabeled Affibody molecule ATH001 targeting PDGFRβ

通过放射性标记的Affibody分子ATH001与PDGFRβ靶向结合的二聚化作用提高了亲和力

EJNMMI Radiopharmacy and Chemistry

IF3.3

2026-03-160

OAAI

PDGFRß targeted positron emission tomography as a non-invasive biomarker for activated hepatic stellate cells: lasts steps before clinical translation

靶向PDGFRß的正电子发射断层扫描作为活化肝星状细胞的非侵入性生物标志物：临床转化前的最后步骤

EJNMMI Radiopharmacy and Chemistry

IF3.3

2025-12-130

OAAI

PET imaging of platelet derived growth factor receptor β in lung fibrosis

肺纤维化中血小板源性生长因子受体β的PET成像

EJNMMI Radiopharmacy and Chemistry

IF3.3

2025-07-150

OAAI

Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2023-11-301

Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer

MOLECULES

IF4.6

2020-12-1810

OAAI

Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer - Influence of Labeling Chemistry on Targeting Properties

放射性标记的GRPR拮抗剂用于弥散性前列腺癌的成像-标记化学对靶向特性的影响

CURRENT MEDICINAL CHEMISTRY

IF3.5

2020-12-0810

PRE

Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model

靶向PSMA和GRPR的异二聚体放射性示踪剂用于前列腺癌成像-通过小鼠模型中的接头修饰优化对PSMA的亲和力

PHARMACEUTICS

IF5.5

2020-07-0123

OAAI

Increase in negative charge of 68Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules

SCIENTIFIC REPORTS

IF3.9

2019-11-2719

OAAI

Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26

SCIENTIFIC REPORTS

IF3.9

2019-11-1920

OAAI

Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts

SCIENTIFIC REPORTS

IF3.9

2019-10-1717

OAAI

Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart

PHARMACEUTICS

IF5.5

2019-08-026

OAAI

Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer

PHARMACEUTICS

IF5.5

2019-07-2320

OAAI

Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2019-05-2335

OAAI

Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting

BIOMATERIALS

IF12.9

2019-05-0122

OAAI

Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake

SCIENTIFIC REPORTS

IF3.9

2019-05-0111

OAAI

Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111

SCIENTIFIC REPORTS

IF3.9

2019-01-2422

OAAI

Affibody-mediated imaging of EGFR expression in prostate cancer using radiocobalt-labeled DOTA-ZEGFR:2377

ONCOLOGY REPORTS

IF3.9

2018-10-156

OAAI

Preclinical Evaluation of [68Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors

CELLS

IF5.2

2018-09-1822

OAAI

Bogdan Mitran

个人简介

教育背景

工作经历

荣誉奖项

研究方向